Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours
Clinical and Translational Medicine · 2024-01 · 14 (1)
DOI: 10.1002/ctm2.1549 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 22.01.2024. Verfasst von Wei Ouyang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: DNA Methylation, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan High-Tech Industry Science and Technology Innovation Leading Plan, the National Key R&D Program of China, Bethune Special Research Fund Project of Urological Oncology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, China.
- Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Urology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medical, Central South University, Changsha, China.
- Department of Urology, Hunan Provincial People's Hospital, First Affiliated Hospital of Hunan Normal University, Changsha, China.
- Department of Urology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, China.
- Yearth Biotechnology Co. Ltd., Changsha, China.
ORCID-Profile: Long Wang
Förderung
- Hunan High-Tech Industry Science and Technology Innovation Leading Plan
- the National Key R&D Program of China
- Bethune Special Research Fund Project of Urological Oncology
Zitieren
APA
Ouyang, W., Xu, R., Yao, H., Jiang, S., Lu, Q., Lv, C., Li, P., Xu, G., Liu, J., & Wang, L. (2024). Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours. Clinical and Translational Medicine, 14(1). https://doi.org/10.1002/ctm2.1549
Vancouver
Ouyang W, Xu R, Yao H, Jiang S, Lu Q, Lv C, et al. Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours. Clinical and Translational Medicine. 2024;14(1). doi:10.1002/ctm2.1549
BibTeX
@article{Ouyang2024,
author = {Ouyang, Wei and Xu, Ran and Yao, Hanyu and Jiang, Shusuan and Lu, Qiang and Lv, Cai and Li, Pei and Xu, Genming and Liu, Jianye and Wang, Long},
title = {Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {1},
doi = {10.1002/ctm2.1549}
}
EUVIMED